Meditope Biosciences Garners $3,600,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=99baaf26-9ff7-4fe1-bea8-1dda3bfe944c - Date
7/27/2013 - Company Name
Meditope Biosciences - Mailing Address
301 North Lake Avenue Pasadena, CA 91101 - Company Description
Discovered at City of Hope, Meditope’s technology is capable of turning any monoclonal antibody (mAb) into a proprietary, site-specific “Lego-like” system that is able to attach and detach drugs to antibodies without the need for chemical conjugation. - Website
http://www.meditope.com - Transaction Type
Venture Equity - Transaction Amount
$3,600,000 - Transaction Round
Series A - Proceeds Purposes
The company will use the proceeds to accelerate development of its antibody-based cancer products. - M&A Terms
- Venture Investor
Undisclosed
